61 related articles for article (PubMed ID: 21965746)
1. ERas enhances resistance to CPT-11 in gastric cancer.
Kubota E; Kataoka H; Tanaka M; Okamoto Y; Ebi M; Hirata Y; Murakami K; Mizoshita T; Shimura T; Mori Y; Tanida S; Kamiya T; Aoyama M; Asai K; Joh T
Anticancer Res; 2011 Oct; 31(10):3353-60. PubMed ID: 21965746
[TBL] [Abstract][Full Text] [Related]
2. Inducible nuclear factor-kappaB activation contributes to chemotherapy resistance in gastric cancer.
Camp ER; Li J; Minnich DJ; Brank A; Moldawer LL; MacKay SL; Hochwald SN
J Am Coll Surg; 2004 Aug; 199(2):249-58. PubMed ID: 15275881
[TBL] [Abstract][Full Text] [Related]
3. Calpain 2-dependent IκBα degradation mediates CPT-11 secondary resistance in colorectal cancer xenografts.
Fenouille N; Grosso S; Yunchao S; Mary D; Pontier-Bres R; Imbert V; Czerucka D; Caroli-Bosc FX; Peyron JF; Lagadec P
J Pathol; 2012 May; 227(1):118-29. PubMed ID: 22069124
[TBL] [Abstract][Full Text] [Related]
4. RRR-α-tocopheryl succinate induces apoptosis in human gastric cancer cells via the NF-κB signaling pathway.
Sun Y; Zhao Y; Hou L; Zhang X; Zhang Z; Wu K
Oncol Rep; 2014 Sep; 32(3):1243-8. PubMed ID: 24970592
[TBL] [Abstract][Full Text] [Related]
5. Curcumin reverses chemoresistance of human gastric cancer cells by downregulating the NF-κB transcription factor.
Yu LL; Wu JG; Dai N; Yu HG; Si JM
Oncol Rep; 2011 Nov; 26(5):1197-203. PubMed ID: 21811763
[TBL] [Abstract][Full Text] [Related]
6. Role of ES cell-expressed Ras (ERas) in tumorigenicity of gastric cancer.
Kubota E; Kataoka H; Aoyama M; Mizoshita T; Mori Y; Shimura T; Tanaka M; Sasaki M; Takahashi S; Asai K; Joh T
Am J Pathol; 2010 Aug; 177(2):955-63. PubMed ID: 20566745
[TBL] [Abstract][Full Text] [Related]
7. Morphoproteomic profile of mTOR, Ras/Raf kinase/ERK, and NF-kappaB pathways in human gastric adenocarcinoma.
Feng W; Brown RE; Trung CD; Li W; Wang L; Khoury T; Alrawi S; Yao J; Xia K; Tan D
Ann Clin Lab Sci; 2008; 38(3):195-209. PubMed ID: 18715846
[TBL] [Abstract][Full Text] [Related]
8. Induction of oncogene addiction shift to NF-kappaB by camptothecin in solid tumor cells.
Togano T; Sasaki M; Watanabe M; Nakashima M; Tsuruo T; Umezawa K; Higashihara M; Watanabe T; Horie R
Biochem Biophys Res Commun; 2009 Dec; 390(1):60-4. PubMed ID: 19778522
[TBL] [Abstract][Full Text] [Related]
9. Resistance to chemotherapeutic agents and promotion of transforming activity mediated by embryonic stem cell-expressed Ras (ERas) signal in neuroblastoma cells.
Aoyama M; Kataoka H; Kubota E; Tada T; Asai K
Int J Oncol; 2010 Oct; 37(4):1011-6. PubMed ID: 20811723
[TBL] [Abstract][Full Text] [Related]
10. First evidence that γ-tocotrienol inhibits the growth of human gastric cancer and chemosensitizes it to capecitabine in a xenograft mouse model through the modulation of NF-κB pathway.
Manu KA; Shanmugam MK; Ramachandran L; Li F; Fong CW; Kumar AP; Tan P; Sethi G
Clin Cancer Res; 2012 Apr; 18(8):2220-9. PubMed ID: 22351692
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of asymmetric curcuminoid analogs as potential anticancer agents that downregulate NF-κB activation and enhance the sensitivity of gastric cancer cell lines to irinotecan chemotherapy.
Qiu P; Zhang S; Zhou Y; Zhu M; Kang Y; Chen D; Wang J; Zhou P; Li W; Xu Q; Jin R; Wu J; Liang G
Eur J Med Chem; 2017 Oct; 139():917-925. PubMed ID: 28881286
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling for analysis acquired oxaliplatin resistant factors in human gastric carcinoma TSGH-S3 cells: the role of IL-6 signaling and Nrf2/AKR1C axis identification.
Chen CC; Chu CB; Liu KJ; Huang CY; Chang JY; Pan WY; Chen HH; Cheng YH; Lee KD; Chen MF; Kuo CC; Chen LT
Biochem Pharmacol; 2013 Oct; 86(7):872-87. PubMed ID: 23933386
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of E2F1 in human gastric carcinoma is involved in anti-cancer drug resistance.
Yan LH; Wei WY; Cao WL; Zhang XS; Xie YB; Xiao Q
BMC Cancer; 2014 Dec; 14():904. PubMed ID: 25466554
[TBL] [Abstract][Full Text] [Related]
14. Nitric Oxide Down-Regulates Topoisomerase I and Induces Camptothecin Resistance in Human Breast MCF-7 Tumor Cells.
Sharma NK; Kumar A; Kumari A; Tokar EJ; Waalkes MP; Bortner CD; Williams J; Ehrenshaft M; Mason RP; Sinha BK
PLoS One; 2015; 10(11):e0141897. PubMed ID: 26540186
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic regulation of the embryonic oncogene ERas in gastric cancer cells.
Yashiro M; Yasuda K; Nishii T; Kaizaki R; Sawada T; Ohira M; Hirakawa K
Int J Oncol; 2009 Nov; 35(5):997-1003. PubMed ID: 19787253
[TBL] [Abstract][Full Text] [Related]
16. Inducible chemoresistance to 7-ethyl-10-[4-(1-piperidino)-1-piperidino]-carbonyloxycamptothe cin (CPT-11) in colorectal cancer cells and a xenograft model is overcome by inhibition of nuclear factor-kappaB activation.
Cusack JC; Liu R; Baldwin AS
Cancer Res; 2000 May; 60(9):2323-30. PubMed ID: 10811101
[TBL] [Abstract][Full Text] [Related]
17. Enhancing the anticancer efficacy of camptothecin using biotinylated poly(ethylene glycol) conjugates in sensitive and multidrug-resistant human ovarian carcinoma cells.
Minko T; Paranjpe PV; Qiu B; Lalloo A; Won R; Stein S; Sinko PJ
Cancer Chemother Pharmacol; 2002 Aug; 50(2):143-50. PubMed ID: 12172980
[TBL] [Abstract][Full Text] [Related]
18. Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells.
Yang L; Zhou Y; Li Y; Zhou J; Wu Y; Cui Y; Yang G; Hong Y
Cancer Lett; 2015 Feb; 357(2):520-6. PubMed ID: 25499080
[TBL] [Abstract][Full Text] [Related]
19. Cetuximab enhances the activities of irinotecan on gastric cancer cell lines through downregulating the EGFR pathway upregulated by irinotecan.
Liu X; Guo WJ; Zhang XW; Cai X; Tian S; Li J
Cancer Chemother Pharmacol; 2011 Oct; 68(4):871-8. PubMed ID: 21286718
[TBL] [Abstract][Full Text] [Related]
20. Rapamycin enhances chemotherapy-induced cytotoxicity by inhibiting the expressions of TS and ERK in gastric cancer cells.
Shigematsu H; Yoshida K; Sanada Y; Osada S; Takahashi T; Wada Y; Konishi K; Okada M; Fukushima M
Int J Cancer; 2010 Jun; 126(11):2716-25. PubMed ID: 19856312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
